Memory Pharmaceuticals Corp. (MEMY) Fundamentals

SHARE INFORMATION
Market Cap$ 49,839,288
Shares Outstanding82,243,050
Float82,243,050
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 11,519,000
Latest Fiscal EPS$ -0.49
Latest Fiscal Date-
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions27
Institutional Holdings Date2008-11-01
Institutional Bought Previous 3 Months718,419
Institutional Holdings Percent26.3%
Institutional Sold Previous 3 Months1,341,319
Insider Holdings Date2008-10-01
Insider Bought Previous 3 Months-
Insider Holdings Percent1.1
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 0.61
52 Week Low$ 0.10
52 Week High Change$ 657.50
21 Day Moving Average$ 0.606
21 Day Extended Moving Average$ 0.00
50 Day Moving Average$ 0.606
50 Day Extended Moving Average$ 0.00
200 Day Moving Average$ 0.606
200 Day Extended Moving Average$ 0.00
10 Day Average Volume50,357
20 Day Average Volume-
30 Day Average Volume-
50 Day Average Volume-
Alpha0.048561
Beta-1.3414
Standard Deviation0.752576
R20.005366
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ 0.00
21 Day Percent Change0.0%
30 Day Price Change$ 0.00
30 Day Percent Change0.0%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ 0.00
Quarter to Date Percent Change0.0%
180 Day Price Change$ 0.00
180 Day Percent Change0.0%
200 Day Price Change$ 0.00
200 Day Percent Change0.0%
Year to Date Price Change$ 0.001
Year to Date Percent Change0.17%

Memory Pharmaceuticals Corp. (MEMY) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 7,113,000
Revenue Per Share$ 0.0865
Revenue (3 Years)$ -7.47
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-2.40
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio0.60
Leverage Ratio0.00
Quick Ratio0.50
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 0
Price to Sales7.0068
Price to Free Cash-1.40
PE High Last 5 Years0.00
Price To Book0.00
Price To Cash Flow-1.20
PE Low Last 5 Years0.00
Price to Tangible Book-2.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.00
Invoice Turnover0.00
Assets Turnover0.20
Return Assets-159.10
Return on Equity0.00
Return on Capital330.30

Memory Pharmaceuticals Corp. (MEMY) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOVaughn M. Kailian
Emplyoees55
Last AuditUQ
CIK0001062216
Industry-
Sector-
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address100 Philips Parkway
Montvale, NJ 7645
Websitewww.memorypharma.com
Facsimile(201) 802-7190
Telephone(201) 802-7100
EmailIR@MemoryPharma.com


Your Recent History
NASDAQ
MEMY
Memory Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.